Compound screening and synthesis for COVID-19 drug development

Biobanque 300x225

Service description

  • The development of small chemical molecules as drugs requires the use of chemical compound libraries in a high-throughput screening (HTS or HCS) and/or the synthesis of compounds by chemical methods.
  • In the context of SARS-CoV-2, typical cell models have been used: Vero-E6, HAE, and ex-vivo respiratory tract models... Library screening would be performed with one of those models.
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the project.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert.

Get started with your COVID-19 compound library screening project

Please answer the fields below to be contacted by our team of scientists

favicon large un peu plus-1